Abstract: The present invention relates to the diagnosis, prognosis and/or treatment of wound infection by testing wound fluid for the presence of a marker which is present in an amount which is indicative of infection. The marker may be high molecular weight phospholipase A2 (cPLA2) or a marker which is correlated with cPLA2.
Type:
Grant
Filed:
June 9, 2005
Date of Patent:
April 1, 2014
Assignee:
Woundcheck Laboratories (US), Inc.
Inventors:
Faraia Shah, Rachael Clark, Patrick John Trotter, Paul William Watt, Breda Mary Cullen